SAN FRANCISCO, May 13, 2022 – Hyfe, Inc., the global leader in AI-powered cough detection and classification, is continuing the expansion of its technology platform that enables medical professionals and researchers to track coughs to better identify and treat respiratory illnesses. Hyfe’s unique ability to unobtrusively recognize, quantify and characterize cough in real time at scale has the potential to improve the lives of patients, the quality of provider’s care, the efficiency of health systems and accelerate the development of new drugs.
Hyfe’s AI-powered technology passively and remotely monitors the number of times a person coughs and the sound of the cough through any smart device, such as a mobile phone. This longitudinal data collected over time provides greater and more reliable information than a single visit to the doctor by revealing patterns and correlations that might otherwise go unnoticed. In addition, Hyfe maintains the largest cough dataset in the world enabling the sound of a patient’s cough to be compared with more than 250 million cough like sounds from 83 countries across all continents.
“The pattern and acoustic characteristics of cough are critical factors in the diagnosis and management of medical conditions,” said Peter Small, M.D., chief medical officer of Hyfe, Inc. “Most people cannot correctly estimate the number of times they cough per day and artificial intelligence can detect nuances in sounds that cannot be heard by the human ear.” Small added that “cough frequency should be measured with the same accuracy as blood pressure, temperature, heartbeat and other biomarkers that are essential for assessing health and illness.”
Hyfe, Inc. is the global leader in AI-powered cough detection and classification that provides insight into cough patterns and correlations that can greatly improve treatment and prevention.
With more than 250 million samples, Hyfe maintains the largest cough dataset in the world enabling the building of powerful models to track, manage and diagnose respiratory illnesses. Hyfe provides platforms and data for pharmaceutical companies, medical researchers, health care providers and patients. The company was founded in 2020 and is headquartered in Wilmington, Delaware More information is available at hyfe.ai, on social media @hyfeapp and LinkedIn at /hyfe.
Press Release: Hyfe Joins Forces with Merck to Deploy Its Artificial Intelligence-Powered Cough Detection and Counting Technology
Hyfe has entered into an agreement with Merck, to integrate its artificial intelligence-powered (AI) cough tracker technology into Merck’s consumer disease educational efforts.
Scientist use Hyfe to to track cough in Long Covid
Scientists use Hyfe to confirm that continuous cough monitoring for Long COVID was more sensitive in evaluating cough variability and response to treatment compared to patient reported outcomes.
Dr. Peter Small, Hyfe, Inc. Chief Medical Officer has Addressed the G20 meeting in Indonesia on the critical impact of digital innovation in combating Tuberculosis
Dr. Peter Small, Hyfe Chief Medical Officer has delivered deliver an intervention to the G20 Meeting in Yogyakarta, Indonesia, on the role of digital innovation in addressing public health crises.